Call for Abstract

42nd Global Psychiatry and Mental Health Conference, will be organized around the theme “Innovative Approaches and Integrative Practices in Global Psychiatry and Mental Health”

Psychiatric 2025 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Psychiatric 2025

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Deep Brain Stimulation (DBS) is an advanced neurosurgical treatment used primarily for movement disorders like Parkinson's disease, and increasingly for psychiatric conditions such as severe depression and obsessive-compulsive disorder (OCD). DBS involves implanting electrodes into specific brain areas, which are then connected to a pacemaker-like device that delivers electrical impulses to modulate abnormal neural activity.

This targeted stimulation can significantly alleviate symptoms that have not responded to conventional therapies. For example, in Parkinson's disease, DBS can reduce tremors, rigidity, and improve motor function. In psychiatric applications, it has shown promise in alleviating treatment-resistant depression by targeting the subcallosal cingulate region.

DBS is typically reserved for patients with severe, debilitating symptoms due to its invasive nature and the complexity of the procedure. However, it offers substantial benefits, providing significant symptomatic relief and improving quality of life. Ongoing research aims to refine this technology and expand its therapeutic applications, heralding a new frontier in neuromodulation treatments.

The role of social media on mental health is a topic of increasing concern and study. While social media platforms offer unprecedented opportunities for connectivity, self-expression, and information sharing, they also present unique challenges and risks to mental well-being.

Excessive use of social media has been associated with a range of mental health issues, including depression, anxiety, loneliness, and low self-esteem. The curated nature of social media content can foster unrealistic comparisons and feelings of inadequacy, leading to negative psychological outcomes.

Moreover, cyberbullying, harassment, and online misinformation further contribute to mental distress among social media users. The constant barrage of notifications and the pressure to maintain online personas can also disrupt sleep patterns and exacerbate stress levels.

While social media can provide valuable support networks and resources for individuals struggling with mental health issues, it is essential to use these platforms mindfully and critically. Developing healthy digital habits, setting boundaries, and prioritizing real-life connections are crucial strategies for mitigating the negative impact of social media on mental health.

The mental health of older adults is a significant aspect of geriatric care, often overlooked but critical for overall well-being. Aging is accompanied by various life transitions, including retirement, loss of loved ones, declining physical health, and changes in social roles, all of which can impact mental health.

Common mental health concerns among older adults include depression, anxiety, cognitive decline, and loneliness. Moreover, older adults may face unique challenges such as chronic illness, caregiver stress, and financial insecurity, further exacerbating psychological distress.

Despite these challenges, older adults often underutilize mental health services due to stigma, accessibility issues, and misconceptions about aging and mental health. However, proactive interventions, including psychotherapy, medication management, social support programs, and lifestyle modifications, can effectively address mental health needs in this population.

Recognizing and addressing the mental health of older adults is essential for promoting healthy aging, enhancing quality of life, and ensuring that older individuals can age with dignity and resilience.

The mental health of children and adolescents is a critical concern with lifelong implications. The formative years are a crucial period for emotional, cognitive, and social development, laying the foundation for future well-being.

Children and adolescents may experience a wide range of mental health challenges, including anxiety disorders, depression, attention-deficit/hyperactivity disorder (ADHD), and behavioral disorders. Factors such as genetics, early childhood experiences, family dynamics, trauma, and environmental stressors can significantly influence mental health outcomes during this period.

Identifying and addressing mental health issues early is essential for preventing long-term consequences. However, stigma, limited access to resources, and inadequate mental health education often hinder timely intervention.

Promoting mental health in children and adolescents requires a multifaceted approach that includes comprehensive screening, early intervention programs, school-based mental health services, and family support. By prioritizing mental health in young populations, we can foster resilience, enhance coping skills, and empower future generations to thrive emotionally and psychologically.

The impact of trauma on mental health is profound and enduring. Trauma, whether experienced in childhood or later in life, can lead to a wide range of psychological difficulties, including post-traumatic stress disorder (PTSD), depression, anxiety disorders, and substance abuse.

Traumatic experiences overwhelm the individual's ability to cope, resulting in lasting changes in brain function, emotion regulation, and interpersonal relationships. The brain's stress response system becomes dysregulated, leading to heightened arousal, hypervigilance, and intrusive memories.

Moreover, trauma can disrupt the development of self-esteem, trust, and attachment patterns, influencing the individual's worldview and sense of safety in the world. Untreated trauma can manifest in maladaptive coping strategies, such as avoidance, dissociation, or self-destructive behavior, further exacerbating mental health symptoms.

Addressing the impact of trauma requires a comprehensive and trauma-informed approach that acknowledges the complexities of trauma's effects on the mind and body. Therapy modalities such as cognitive-behavioral therapy (CBT), eye movement desensitization and reprocessing (EMDR), and somatic experiencing offer effective strategies for healing and restoring mental well-being.

The importance of sleep for mental health cannot be overstated. Sleep is a fundamental physiological process that plays a critical role in regulating mood, cognition, and emotional well-being. During sleep, the brain undergoes essential processes such as memory consolidation, synaptic pruning, and neurotransmitter regulation, all of which are vital for maintaining optimal mental functioning.

Chronic sleep disturbances, such as insomnia or sleep apnea, have been linked to an increased risk of developing psychiatric disorders, including depression, anxiety, bipolar disorder, and schizophrenia. Conversely, improving sleep quality has been shown to alleviate symptoms of these conditions and enhance overall mental health.

Sleep deprivation disrupts neurochemical balance, impairs decision-making, and exacerbates emotional reactivity, leading to heightened stress levels and reduced resilience to psychological challenges. Recognizing the profound impact of sleep on mental health underscores the importance of prioritizing healthy sleep habits as a cornerstone of holistic well-being.

The neurobiology of mental health delves into the intricate interplay between brain function and psychological well-being. Complex neural circuits, neurotransmitter systems, and genetic factors collectively influence mental health outcomes.

Research indicates that abnormalities in neurotransmitter activity, particularly serotonin, dopamine, and norepinephrine, play a pivotal role in mood regulation and emotional stability. Structural and functional alterations in brain regions such as the prefrontal cortex, amygdala, and hippocampus are observed in various psychiatric disorders, impacting cognition, emotion, and behavior.

Furthermore, genetic predispositions, environmental stressors, and epigenetic modifications can modulate neural circuitry and contribute to the development of mental illness. Understanding the neurobiological underpinnings of conditions like depression, anxiety, and schizophrenia informs the development of targeted interventions, including pharmacotherapy, psychotherapy, and neuromodulation techniques.

By unraveling the complexities of brain function and mental health, neurobiology offers insights into the pathophysiology of psychiatric disorders and paves the way for personalized treatment approaches tailored to individual needs.

In recent years, scientific understanding has increasingly recognized the profound impact of inflammation on mental health. While inflammation is a natural immune response, chronic or excessive inflammation can detrimentally affect the brain and contribute to mental illness.

Research indicates that inflammation disrupts neurotransmitter function, alters neural circuitry, and impairs neuroplasticity, all of which can lead to mood disorders such as depression and anxiety. Elevated levels of inflammatory markers have been consistently observed in individuals with various psychiatric conditions.

Moreover, inflammatory processes may play a role in the onset and progression of neurodegenerative disorders like Alzheimer's disease and Parkinson's disease. Lifestyle factors such as diet, stress, and sleep quality can influence inflammation levels and, consequently, mental well-being.

Understanding the intricate interplay between inflammation and mental health holds promise for developing novel treatment approaches that target immune dysregulation, offering hope for more effective interventions and improved outcomes for individuals living with mental illness.

The gut-brain connection, a burgeoning field in neuroscience and gastroenterology, explores the bidirectional communication between the gastrointestinal system and the brain. This intricate relationship is mediated by the enteric nervous system, gut microbiota, and various biochemical signaling pathways.

Research has demonstrated that the gut microbiome plays a crucial role in influencing mood, cognition, and overall mental health. For instance, alterations in gut bacteria composition have been linked to conditions such as depression, anxiety, and even neurodegenerative diseases like Parkinson's.

Neurotransmitters produced in the gut, such as serotonin and dopamine, significantly impact brain function and emotional well-being. Moreover, the vagus nerve acts as a direct communication highway between the gut and the brain, transmitting signals that can affect stress responses and inflammation.

Understanding the gut-brain connection opens new avenues for treating mental health disorders through dietary interventions, probiotics, and lifestyle modifications, offering a holistic approach to well-being that integrates both physical and mental health.

Mental health, a critical aspect of overall health, encompasses emotional, psychological, and social well-being. It influences cognition, perception, and behavior, affecting how individuals handle stress, relate to others, and make decisions. Throughout life, mental health is shaped by various factors, including biological factors (such as genetics and brain chemistry), life experiences (such as trauma or abuse), and family history of mental health problems.

Common Mental Health Disorders

Mental health disorders are among the leading causes of disability worldwide. Common disorders include:

  1. Depression: Characterized by persistent sadness, loss of interest, and a range of emotional and physical problems.
  2. Anxiety Disorders: Include generalized anxiety disorder, panic disorder, and social anxiety disorder, involving excessive fear or anxiety.
  3. Bipolar Disorder: Involves episodes of mood swings ranging from depressive lows to manic highs.
  4. Schizophrenia and Other Psychotic Disorders: Severe disorders affecting thinking, emotions, and behavior, often involving psychosis.
  5. Obsessive-Compulsive Disorder (OCD): Characterized by unwanted repetitive thoughts and/or actions.
  6. Post-Traumatic Stress Disorder (PTSD): Triggered by experiencing or witnessing a traumatic event.

Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation technique used to treat depression and other psychiatric conditions. By generating magnetic fields, TMS stimulates specific brain regions, particularly the prefrontal cortex, which is often underactive in depression.

TMS is typically administered in outpatient settings, with sessions lasting about 20-40 minutes over several weeks. Unlike electroconvulsive therapy (ECT), TMS does not require anesthesia and has fewer cognitive side effects. Patients usually experience only mild discomfort at the treatment site.

Clinical studies have demonstrated TMS's efficacy in alleviating symptoms of treatment-resistant depression, with many patients achieving significant improvement or remission. The mechanism involves modulating neural activity and enhancing synaptic plasticity, contributing to better mood regulation.

While TMS is generally well-tolerated, some patients may experience headaches or scalp discomfort. As research progresses, TMS is expanding its applications, offering a promising, evidence-based option for individuals unresponsive to conventional treatments.

Ketamine, traditionally an anesthetic, has emerged as a revolutionary treatment for depression, especially treatment-resistant depression. Unlike conventional antidepressants, which can take weeks to show effects, ketamine often produces rapid antidepressant effects within hours. This fast-acting nature makes it a critical option for patients in acute depressive episodes.

Administered in controlled, clinical settings, ketamine works by modulating the brain's glutamate system, promoting synaptic plasticity and neural connectivity. Studies have shown that even low doses can significantly alleviate depressive symptoms, offering relief when other treatments have failed.

Despite its promise, ketamine therapy is not without challenges. The potential for abuse, side effects like dissociation, and the need for repeated administration to maintain benefits are critical considerations. Additionally, long-term safety data is still being accumulated. Nevertheless, ketamine's rapid action and efficacy herald a promising advancement in the treatment of severe depression, providing new hope for those who have exhausted other options.

Precision psychiatry is an emerging field that aims to tailor mental health treatment to individual patients based on their genetic, biological, and psychosocial characteristics. By moving away from the one-size-fits-all approach, precision psychiatry seeks to enhance the accuracy and effectiveness of diagnoses and interventions.

This innovative approach leverages advances in genomics, neuroimaging, and data analytics to identify biomarkers and patterns that predict how patients will respond to specific treatments. For instance, genetic testing can help determine which antidepressant is most likely to be effective for a particular patient, while neuroimaging can reveal brain activity patterns associated with various psychiatric conditions.

Early research in precision psychiatry has shown promise in improving outcomes for conditions like depression, schizophrenia, and bipolar disorder. However, challenges such as integrating complex data and ensuring ethical use of genetic information remain. Despite these hurdles, precision psychiatry represents a significant step forward in personalized mental healthcare, offering hope for more effective and targeted treatments.

Digital therapeutics (DTx) represent a cutting-edge approach to healthcare, leveraging software-based interventions to prevent, manage, or treat medical conditions. These evidence-based therapeutic interventions are delivered via mobile apps, wearable devices, and other digital platforms, offering a personalized and scalable solution to healthcare.

DTx encompasses a broad range of applications, from managing chronic diseases like diabetes and hypertension to addressing mental health conditions such as anxiety and depression. By combining behavioral science, artificial intelligence, and real-time data analysis, digital therapeutics provide tailored treatment plans and continuous patient monitoring.

Clinical trials have demonstrated the efficacy of DTx in improving health outcomes and patient adherence to treatment protocols. For example, digital cognitive-behavioral therapy (CBT) programs have shown significant success in treating insomnia and depression. Despite regulatory and adoption challenges, digital therapeutics hold immense promise for revolutionizing healthcare by making effective, personalized treatment more accessible and affordable.

Microdosing, the practice of consuming sub-perceptual doses of psychedelic substances like LSD or psilocybin, has gained popularity for its potential cognitive and emotional benefits without inducing significant alterations in consciousness. Typically, individuals take about 1/10th to 1/20th of a standard dose, enough to enhance creativity, focus, and mood without causing hallucinations.

Research on microdosing is still in its early stages, but anecdotal reports and preliminary studies suggest improvements in mental health, such as reduced anxiety and depression, increased productivity, and enhanced problem-solving abilities. The subtle effects of microdosing are thought to result from the modulation of neural pathways associated with mood regulation and cognitive function.

However, the practice is not without controversy. The long-term effects and safety of regular microdosing remain unclear, and legal restrictions on psychedelic substances pose significant barriers to comprehensive research. Despite these challenges, microdosing continues to intrigue both the scientific community and the general public as a potential tool for mental and cognitive enhancement.

Psychedelic-assisted therapies are gaining traction as innovative treatments for mental health disorders. Utilizing substances like psilocybin, MDMA, and LSD, these therapies are conducted under professional supervision to address conditions such as depression, PTSD, and anxiety.

The process combines psychedelic experiences with traditional psychotherapy, enabling patients to access repressed memories and emotions. This can lead to profound insights and lasting emotional healing. Research has demonstrated significant improvements in mental health, often with just a few sessions. For example, MDMA-assisted therapy has shown notable success in reducing PTSD symptoms, while psilocybin has been effective against treatment-resistant depression.

Despite the promising results, challenges remain, including regulatory barriers, the risk of misuse, and the necessity for specialized therapist training. Nevertheless, as studies advance, psychedelic-assisted therapies offer a transformative potential for those unresponsive to conventional treatments, heralding a new era in mental health care.

The COVID-19 pandemic has profoundly affected global health, extending far beyond the direct physical impacts of the virus. The pandemic's ramifications on mental health are significant and widespread, influencing individuals, families, communities, and healthcare systems. This article delves into the mental health consequences of the COVID-19 pandemic, examining the multifaceted challenges it has introduced, the populations most affected, and the strategies needed to address these pressing issues.

Stress and Anxiety

The uncertainty and unpredictability of the COVID-19 pandemic have led to heightened levels of stress and anxiety. Factors contributing to this include fear of infection, concerns about the health of loved ones, financial instability, and the constant influx of information and misinformation. The World Health Organization (WHO) has highlighted a significant increase in the prevalence of anxiety disorders globally during the pandemic.

Depression and Loneliness

Lockdowns, social distancing measures, and the reduction of social interactions have exacerbated feelings of loneliness and isolation. Many individuals have experienced a deterioration in their mental health, manifesting in increased rates of depression. The disruption of daily routines, coupled with the loss of physical contact and social support networks, has contributed to a pervasive sense of isolation and sadness.

Trauma and Grief

For those directly affected by COVID-19, either through personal illness or the loss of loved ones, the pandemic has been a source of profound trauma and grief. The inability to perform traditional mourning rituals and the often abrupt and isolated nature of deaths due to the virus have complicated the grieving process, leading to prolonged and complicated grief for many.